Plasma p-tau217 Blood Test Identified Alzheimer’s Pathology in Meta-Analysis

Plasma p-tau217 Blood Test Identified Alzheimer's Pathology in Meta-Analysis

TL;DR: A 2026 systematic review and meta-analysis in Molecular Neurobiology found that plasma phosphorylated tau 217 (p-tau217), a blood marker of Alzheimer-linked tau pathology, identified biomarker-defined Alzheimer’s disease with pooled sensitivity of 85.4% and specificity of 88.0% across 27 studies. Key Findings 27-study evidence base: Researchers analyzed 19,652 participants from studies that compared plasma p-tau217 …

Read more

Plasma p-tau217 Blood Test Predicts Alzheimer’s Symptom Onset within 3 Years (2026 Research)

Blood Test Predicts Alzheimer’s 3-4 Years Early TL;DR: A blood test measuring phosphorylated tau-217 can predict when cognitively normal people will develop Alzheimer’s symptoms with a 3.0-3.7 year margin of error, potentially transforming how researchers identify candidates for preventive clinical trials. For decades, Alzheimer’s disease remained invisible until symptoms emerged. Brain scans could show amyloid …

Read more